Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27847342 | 0.86 | GPR119 (0.38) | GPR119ACHEKDM4EKMT2A | |
| SCHEMBL1773896 | 0.85 | GPR119 (0.56) | GPR119MAPTSMN1; SMN2GAATHRB | |
| SCHEMBL1269808 | 0.85 | GPR119 (0.51) | GPR119ACHEMAPTSMN1; SMN2F2RL3 | |
| SCHEMBL1773739 | 0.85 | FAAH (0.41) | FAAHKDM4EKMT2A | |
| SCHEMBL30926236 | 0.82 | GPR119 (0.58) | GPR119MAPTSMN1; SMN2F2RL3GAA | |
| SCHEMBL3144261 | 0.81 | GPR119 (0.60) | GPR119MAPTSMN1; SMN2F2RL3GAA | |
| SCHEMBL1118205 | 0.79 | GPR119 (0.72) | GPR119SMN1; SMN2F2RL3GAATHRB | |
| SCHEMBL907209 | 0.79 | GPR119 (0.58) | GPR119MAPTSMN1; SMN2F2RL3GAA | |
| SCHEMBL1269323 | 0.79 | GPR119 (0.58) | GPR119MAPTSMN1; SMN2F2RL3GAA | |
| SCHEMBL17350987 | 0.78 | GRM2 (0.39) | MAPTPKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334669-B1 | HETEROCYCLYL-SUBSTITUTED THIAZOLES AS PLANT PROTECTION AGENTS | BAYER IP GMBH (DE) | 2015-12-23 | — | — | EP | disclosed |
| US-7943774-B2 | Heterocyclyl-substituted thiazoles as crop protection agents | BAYER CROPSCIENCE AG (DE) | 2011-05-17 | — | — | US | disclosed |
| US-20100137245-A1 | Heteerocyclyl-substituted thiazoles as crop protection agents | BAYER CROPSCIENCE AG (DE) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137245-A1 | Heteerocyclyl-substituted thiazoles as crop protection agents | CYP8B1, CYP51A1, HPD | GPR119 3388/4885ACHE 3702/4885MAPT 3632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.